ES2155131T3 - Proceso para la fabricacion de dispositivos para la liberacion controlada de principios activos. - Google Patents

Proceso para la fabricacion de dispositivos para la liberacion controlada de principios activos.

Info

Publication number
ES2155131T3
ES2155131T3 ES95920805T ES95920805T ES2155131T3 ES 2155131 T3 ES2155131 T3 ES 2155131T3 ES 95920805 T ES95920805 T ES 95920805T ES 95920805 T ES95920805 T ES 95920805T ES 2155131 T3 ES2155131 T3 ES 2155131T3
Authority
ES
Spain
Prior art keywords
devices
controlled release
manufacture
active principles
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95920805T
Other languages
English (en)
Inventor
Karsten Cremer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2155131T3 publication Critical patent/ES2155131T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Moulds For Moulding Plastics Or The Like (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

UN PROCEDIMIENTO PARA LA OBTENCION DE DISPOSITIVOS PARA LA LIBERACION CONTROLADA DE PRINCIPIOS ACTIVOS, QUE SE COMPONE DE UNA MATRIZ QUE CONTIENE EL PRINCIPIO ACTIVO Y DE UNA MASA SOLIDA EROSIONABLE QUE CUBRE AL MENOS PARCIALMENTE LA MATRIZ, ESTANDO DETERMINADO EL GROSOR DE LA MASA EROSIONABLE EN TODA SU EXTENSION POR GRADIENTES DE GROSOR, ESTE PROCEDIMIENTO SE CARACTERIZA PORQUE LA MASA EROSIONABLE SE UNE A LA MATRIZ QUE CONTIENE LOS PRINCIPIOS ACTIVOS DESPUES DE LA FORMACION DE LA MATRIZ.
ES95920805T 1994-05-13 1995-05-08 Proceso para la fabricacion de dispositivos para la liberacion controlada de principios activos. Expired - Lifetime ES2155131T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4416926A DE4416926C2 (de) 1994-05-13 1994-05-13 Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Wirkstoffen

Publications (1)

Publication Number Publication Date
ES2155131T3 true ES2155131T3 (es) 2001-05-01

Family

ID=6518074

Family Applications (2)

Application Number Title Priority Date Filing Date
ES95920805T Expired - Lifetime ES2155131T3 (es) 1994-05-13 1995-05-08 Proceso para la fabricacion de dispositivos para la liberacion controlada de principios activos.
ES99114947T Expired - Lifetime ES2224505T3 (es) 1994-05-13 1995-05-08 Procedimiento para fabricar dispositivos para la liberacion controlada de medicamentos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99114947T Expired - Lifetime ES2224505T3 (es) 1994-05-13 1995-05-08 Procedimiento para fabricar dispositivos para la liberacion controlada de medicamentos.

Country Status (10)

Country Link
EP (2) EP0965337B1 (es)
JP (1) JPH10500118A (es)
AT (2) ATE198151T1 (es)
CA (1) CA2189991C (es)
DE (3) DE4416926C2 (es)
DK (1) DK0758884T3 (es)
ES (2) ES2155131T3 (es)
GR (1) GR3035533T3 (es)
PT (1) PT758884E (es)
WO (1) WO1995031185A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19524753A1 (de) * 1995-07-07 1997-01-23 Lohmann Therapie Syst Lts Schichttablette zur kontrollierten Freisetzung von Wirkstoffen
DE19640062B4 (de) 1996-09-28 2006-04-27 Lts Lohmann Therapie-Systeme Ag Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff
US20050037052A1 (en) * 2003-08-13 2005-02-17 Medtronic Vascular, Inc. Stent coating with gradient porosity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
WO1994007470A1 (en) * 1992-09-30 1994-04-14 Pfizer Inc. Article containing a core and a coating having a non constant thickness
CN1029660C (zh) * 1993-02-17 1995-09-06 杨吉田 药物非平面膜剂及其制备工艺
DE4341442C2 (de) * 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung

Also Published As

Publication number Publication date
WO1995031185A1 (de) 1995-11-23
EP0965337A1 (de) 1999-12-22
DK0758884T3 (da) 2001-04-30
DE4416926C2 (de) 2000-01-13
ATE271855T1 (de) 2004-08-15
DE59508911D1 (de) 2001-01-25
DE59510932D1 (de) 2004-09-02
EP0758884A1 (de) 1997-02-26
EP0758884B1 (de) 2000-12-20
EP0965337B1 (de) 2004-07-28
DE4416926A1 (de) 1995-11-16
ES2224505T3 (es) 2005-03-01
CA2189991C (en) 2006-09-12
GR3035533T3 (en) 2001-06-29
JPH10500118A (ja) 1998-01-06
ATE198151T1 (de) 2001-01-15
CA2189991A1 (en) 1995-11-23
PT758884E (pt) 2001-06-29

Similar Documents

Publication Publication Date Title
PT90153A (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao controlada
CO5190681A1 (es) Formas de dosificacion farmaceutica para la liberacion controlada que producen al menos un impulso ciclico
ATE186211T1 (de) Verfahren zu herstellung einer manteltablette mit spitzem kern
DK151529C (da) Vaginalring med et lag aktivt steroid
NO995908L (no) Implantater for kontrollert frigivning av farmasoeytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav
BR8900161A (pt) Preservativo profilatico contraceptivo,processo para a fabricacao do mesmo e forro de suporte
SE9102072L (sv) Oral, fast, farmaceutisk doseringsform med styrd frisaettning
EP0743047A3 (en) Anatomically shaped device for vascular occlusion and its manufacturing process
PT98497A (pt) Processo para a preparacao de particulas para a libertacao controlada de um ingrediente activo
ES2151045T3 (es) Dispositivo para la liberacion controlada de principios activos.
MX9200257A (es) Transistor de pelicula delgada de polisilicio y prtransistor de pelicula delgada de polisilicio y proceso para su fabricacion. oceso para su fabricacion.
KR970702778A (ko) 종이 뜨는 방법의 스탬퍼블 시트, 경량 스탬퍼블 시트 성형체 및 경량 스탬퍼블 시트 성형체의 제조방법(Paper-Made Stampable Sheet, Light-Weight Stampable Sheet Shaped Body And Method Of Producing Light-Weight Stampable Shaped Body)
DK0386440T3 (da) Lægemidler med kontrolleret afgivelse af virksomt stof
HUP9801765A3 (en) Substrate with super-absorbent material, method for manufacture thereof and use
AU567434B2 (en) A crystallised carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
EE03955B1 (et) Nukleiinhappe kasutamine ravimi valmistamiseks imetaja reproduktiivtrakti vähemalt mõne raku transfekteerimiseks
IT1204294B (it) Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
NO821716L (no) Kaldformbart, kunststoffbundet hoeyenergisprengstoff, samt fremgangsmaate for dets fremstilling
ES2180774T3 (es) La utilizacion de triacetato de glicerilo para el tratamiento de onicomicosis.
ES2108138T3 (es) Matriz termocoloide controlada por la forma sol a base de gelatina para formas perorales de liberacion retardada.
FI891865A7 (fi) Atselastiinia sisältäviä lääkkeitä, joista vaikuttava aine vapautuu säädellysti
ES2155131T3 (es) Proceso para la fabricacion de dispositivos para la liberacion controlada de principios activos.
AR001078A1 (es) Forma farmacéutica destinada a la cesión de colagenasa en heridas y procedimiento para su elaboración
NO980861L (no) Granulat med risleevne og basert på organiske syrer, fremgangsmåte for fremstilling, samt anvendelse
NO884721D0 (no) Fremgangsmaate ved fremstilling av biologisk aktive komponenter.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 758884

Country of ref document: ES